STOCK TITAN

Rule 10b5-1 sale: TD SYNNEX (NYSE: SNX) director sells 5,000 shares

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

TD SYNNEX CORP director Richard T. Hume reported open-market sales of a total of 5,000 shares of TD SYNNEX common stock on May 5, 2026. The shares were sold in multiple blocks at prices between approximately $230 and $235 per share.

According to the filing, these transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted by Hume on February 2, 2026. All transactions involved non-derivative common stock, and the filing does not show any option exercises or derivative activity.

Positive

  • None.

Negative

  • None.

Insights

Director’s 5,000-share planned sale looks like routine liquidity.

Richard T. Hume, a director of TD SYNNEX CORP, sold 5,000 shares of common stock on May 5, 2026 through a series of open-market transactions. Sale prices ranged from about $230.71 to $234.915 per share.

The filing states these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Such plans are designed to schedule trades in advance, reducing the significance of trade timing as a signal of insider sentiment. No derivative exercises or tax-related dispositions are reported.

From this single filing, the main takeaway is a net sale of 5,000 shares of common stock with no change disclosed in derivative positions. Future company filings may provide additional context on his overall holdings and any further plan-driven transactions.

Insider HUME RICHARD T
Role null
Sold 5,000 shs ($1.17M)
Type Security Shares Price Value
Sale Common Stock 93 $230.72 $21K
Sale Common Stock 78 $231.48 $18K
Sale Common Stock 856 $232.73 $199K
Sale Common Stock 924 $233.45 $216K
Sale Common Stock 3,049 $234.44 $715K
Holdings After Transaction: Common Stock — 38,444 shares (Direct, null)
Footnotes (1)
  1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2026. Represents the weighted average sales price for a number of transactions effected at prices ranging from $230.71 to $230.82. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $231.23 to $231.55. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $232.39 to $232.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $233.005 to $233.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $234.095 to $234.915. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
Shares sold 5,000 shares Total common stock sold on May 5, 2026
Sale block 1 3,049 shares at $234.44 Open-market sale of common stock
Sale block 2 924 shares at $233.45 Open-market sale of common stock
Sale block 3 856 shares at $232.73 Open-market sale of common stock
Sale block 4 78 shares at $231.48 Open-market sale of common stock
Sale block 5 93 shares at $230.72 Open-market sale of common stock
Rule 10b5-1 trading plan regulatory
"These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"Represents the weighted average sales price for a number of transactions effected at prices"
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
""transaction_type": "non-derivative""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HUME RICHARD T

(Last)(First)(Middle)
5350 TECH DATA DRIVE

(Street)
CLEARWATER FLORIDA 33760

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/05/2026S(1)93D$230.72(2)38,444D
Common Stock05/05/2026S(1)78D$231.48(3)38,366D
Common Stock05/05/2026S(1)856D$232.73(4)37,510D
Common Stock05/05/2026S(1)924D$233.45(5)36,586D
Common Stock05/05/2026S(1)3,049D$234.44(6)33,537D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2026.
2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $230.71 to $230.82. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $231.23 to $231.55. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $232.39 to $232.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
5. Represents the weighted average sales price for a number of transactions effected at prices ranging from $233.005 to $233.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
6. Represents the weighted average sales price for a number of transactions effected at prices ranging from $234.095 to $234.915. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
Remarks:
/s/ Cheryl Grant, attorney-in-fact05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TD SYNNEX (SNX) report for Richard T. Hume?

TD SYNNEX director Richard T. Hume reported selling 5,000 shares of common stock on May 5, 2026. The shares were sold in several open-market trades at prices generally between $230 and $235 per share, according to the Form 4 filing.

Was the TD SYNNEX (SNX) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were executed under a Rule 10b5-1 trading plan adopted by Richard T. Hume on February 2, 2026. Such pre-arranged plans schedule trades in advance, which can make the timing less indicative of his short-term market view.

How many TD SYNNEX (SNX) shares did Richard T. Hume sell and on what date?

The Form 4 shows that Richard T. Hume sold a total of 5,000 TD SYNNEX common shares on May 5, 2026. These were reported as non-derivative, open-market sales, split into several transactions at different per-share prices.

At what prices were the TD SYNNEX (SNX) insider shares sold?

Individual open-market sales were executed at weighted-average prices tied to narrow price ranges. The disclosed ranges span from $230.71 to $234.915 per share, with each footnote specifying the exact range applicable to the corresponding transaction line.

Did the TD SYNNEX (SNX) Form 4 include any option exercises or derivative trades?

No. The reported transactions all involve non-derivative TD SYNNEX common stock, coded as open-market sales. The derivativeSummary section is empty in this filing, indicating no option exercises, conversions, or other derivative transactions were reported for this date.